Cerliponase alfa
Brineura (cerliponase alfa) is an enzyme pharmaceutical. Cerliponase alfa was first approved as Brineura on 2017-04-27. It is used to treat neuronal ceroid-lipofuscinoses in the USA. It has been approved in Europe to treat neuronal ceroid-lipofuscinoses.
| Trade Name | Brineura |
|---|---|
| Common Name | Cerliponase alfa |
| Indication | neuronal ceroid-lipofuscinoses |
| Drug Class | Enzymes |
